3-Nitropropionic acid-induced neurotoxicity - Assessed by ultra high resolution positron emission tomography with comparison to magnetic resonance spectroscopy

Journal of Neurochemistry

Volumn 89, Issue 5, 2004, Pages 1206-1214

  Brownell, Anna Liisa ^a   Chen, Y Iris ^a   Yu, Meixiang ^a   Wang, Xukui ^a   Dedeoglu, Alpaslan ^b   Cicchetti, Francesca ^c   Jenkins, Bruce G ^a   Beal, M Flint ^d  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c LAVAL UNIVERSITY   (Canada)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

3 Nitropropionic acid; Glucose utilization; Huntington's disease; Magnetic resonance spectroscopy; Neurodegeneration; Positron emission tomography

Indexed keywords

3 NITROPROPIONIC ACID; FLUORODEOXYGLUCOSE F 18; LACTIC ACID; N ACETYLASPARTIC ACID; SUCCINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; BRAIN CORTEX; BRAIN INJURY; CONTROLLED STUDY; CORPUS STRIATUM; DEGENERATION; ENERGY METABOLISM; GLUCOSE UTILIZATION; INTERMETHOD COMPARISON; LOCOMOTION; LONGITUDINAL STUDY; MACROMOLECULE; MALE; NEUROCHEMISTRY; NEUROTOXICITY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION;

ACUTE DISEASE; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; BRAIN; CHOLINE; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENERGY METABOLISM; FLUORODEOXYGLUCOSE F18; GLUCOSE; LACTIC ACID; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MOTOR ACTIVITY; NEOSTRIATUM; NEUROTOXICITY SYNDROMES; NITRO COMPOUNDS; PROPIONIC ACIDS; RATS; RATS, SPRAGUE-DAWLEY; SUCCINIC ACID; TOMOGRAPHY, EMISSION-COMPUTED;

ANIMALIA;

EID: 2642573312     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02408.x     Document Type: Article

References (42)

1. Albin L. and Greenamyre J. T. (1992) Alternative excitotoxic hypothesis. Neurology 42, 733-738.
2. Alston T. A., Mela L. and Bright H. J. (1977) 3-Nitropropionate, the toxic substance of Indiofera, is a suicide inactivator of succinate dehydrogenase. Proc. Natl. Acad. Sci. USA 74, 3767-3771.
3. Antonini A., Kazumata K., Feigin A., Mandel F., Dhawan V., Margouleff C. and Eidelberg D. (1998) Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET. Mov. Disord. 13, 268-274.
4. Beal M. F. (1992) Does impairment of energy metabolism result in exitotoxic neural death in neurodegenerative illness. Ann. Neurol. 31, 119-130.
5. Beal M. F. (1998) Mitochondrial dysfunction in neurodegenerative diseases. Biochim. Biophys. Acta 1366, 211-223.
6. Beal M. F., Brouillet E., Jenkins B. G., Ferrante R. J., Kowall N. W., Miller J. M., Storey E., Srivastava R., Rosen B. R. and Hyman B. T. (1993) Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurochem. 13, 4181-4192.
7. Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V. and Greenamyre J. T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 1301-1306.
8. Blum D., Gall D., Cuvelier L. and Schiffinann S. N. (2001) Topological analysis of striatal lesions induced by 3-nitropropionic acid in the Lewis rat. Neuroreport 12, 1769-1772.
9. Borlongan C., Koutouzis T. K., Freeman T. B., Hauser R. A., Cahill D. W. and Sanberg P. R. (1997) Hyperactivity and hypoacfivity in a rat model of Huntington's disease: the systemic 3-nitropropionic acid model. Brain Res. Protoc. 1, 253-257.
10. Brennan W. A. J., Bird E. D. and Aprille J. R. (1985) Regional mitochondrial respiratory activity in Huntington's disease brain. J. Neurochem. 44, 1948-1950.
11. Brouillet E., Guyot M. C., Mittoux V., Altaire S., Conde F., Palfi S. and Hantraye P. (1998) Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. J. Neurochem. 70, 794-805.
12. Brownell A.-L., Kano M., McKinstry R. C., Moskowitz M. A., Rosen B. R. and Brownell G. L. (1991) PET and MR studies of experimental focal stroke. J. Comput. Assist. Tomogr. 15, 376-380.
13. Cepeda C., Colwell C. S., Itri J. N., Gruen E. and Levine M. S. (1998) Dopaminergic modulation of early signs of excitotoxicity in visualized rat neostriatal neurons. Eur. J. Neurosci. 10, 4391-4397.
14. Correia J., Burnham C., Kaufman D. and Fischman A. (1999) Development of a small animal PET imaging device with resolution approaching 1mm. IEEE Trans. Nucl. Sci. 46, 631-635.
15. Dautry C., Vaufrey F., Brouillet E., Bizat N., Henry P. G., Conde F., Bloch G. and Hantraye P. (2000) Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitropropionic acid. J. Cereb. Blood Flow Metab. 20, 789-799.
16. Dethy S., van Blercom N., Damhaut P., Wikler D., Hildebrand J. and Goldman S. (1998) Asymmetry of basal gan glia glucose metabolism and dopa responsiveness in parkinsonism. Mov. Disord. 13, 275-280.
17. Di Chiro G. (1987) Positron emission tomography using [18F]fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool. Invest. Radiol. 22, 360-371.
18. Eberling J., Richardson B. C., Reed B. R., Wolfe N. and Jagust W. J. (1994) Cortical glucose metabolism in Parkinson's disease without dementia. Neurobiol. Aging 15, 329-335.
19. Eidelberg D., Moeller J. R., Ishikawa T. et al. (1996) Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease. Ann. Neurol. 39, 452-459.
20. El Massioui N., Ouary S., Cheruel F., Hantraye P. and Brouillet E. (2001) Perseverative behavior underlying attentional set-shifting deficit in rats chronically treated with the neurotoxin 3-nitropropionic acid. Exp. Neurol. 172, 172-181.
21. Fink S. L., Ho D. Y. and Sapolsky R. M. (1996) Energy and glutamate dependency of 3-nitropropionic acid neurotoxicity in culture. Exp. Neurol. 138, 298-304.
22. Foster D. M. (1994) SAAM II: simulation, analysis and modeling software. BMES Bull. 18, 19-21.
23. Garcia M., Vanhoutte P., Pages C., Besson M. J., Brouillet E. and Caboche J. (2002) The mitochondrial toxin 3-nitropropionic acid induces striatal neurodegeneration via a c-Jun N-terminal kinase/c-Jun module. J. Neurosci. 22, 2174-2184.
24. Guo Z., Ersoz A., Butterfield D. A. and Mattson M. P. (2000) Beneficial effects of dietary restriction on cerebral cortical synaptic terminals: preservation of glucose and glutamate transport and mitochondrial function after exposure to amyloid beta-peptide, iron, and 3-nitropropionic acid. J. Neurochem. 75, 314-320.
25. Guyot M.-C., Hantraye P., Dolan R., Palfi S., Maziere M. and Brouillet E. (1997) Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Neuroscience 79, 45-56.
26. Higashi K., Ueda Y., Yagishita M., Arisaka Y., Sakurai A., Ogushi M., Seki H., Nambu Y., Tonami H. and Yamamoto I. (2000) FDG PET measurement of the proliferative potential of non-small cell lung cancer. J. Nucl. Med. 41, 85-92.
27. Huntington's Disease Collaborative Group (1993) A novel gene containing a trinucleotide repeat is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971-983.
28. Jenkins B. G., Brouillet E., Chen Y. C., Storey E., Schultz J. B., Kirschner P., Beal M. F. and Rosen B. R. (1996) Non-invasive neurochemical analysis of focal excitotoxic lesions in models of neurodegenerative illness using spectroscopic imaging. J. Cereb. Blood Flow Metab. 16, 450-461.
29. Johnson J., Robinson B. L., Ali S. F. and Binienda Z. (2000) Dopamine toxicity following long term exposure to low doses of 3-nitropropionic acid (3-NP) in rats. Toxicol. Lett. 116, 113-118.
30. Kim G. W. and Chan P. H. (2001) Oxidative stress and neuronal DNA fragmentation mediate age-dependent vulnerability to the mitochondrial toxin, 3-nitropropionic acid, in the mouse striatum. Neurobiol. Dis. 8 (1 Part B), 114-126.
31. Lee W.-T., Lee C.-S., Pan Y.-L. and Chang C. (2000) Temporal changes of cerebral metabolites and straital lesions in acute 3-nitropropionic acid intoxication in the rat. Magn. Reson. Med. 44, 29-34.
32. Ludolph A. C., He F., Spencer P. S., Hammerstad J. and Sabri M. (1991) 3-nitropropionic acid - Exogenous animal neurotoxin and possible human striatal toxin. Can. J. Neurol. Sci. 18, 492-498.
33. Ouary S., Bizat N., Altairac S., Menetrat H., Mittoux V., Conde F., Hantraye P. and Brouillet E. (2000) Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies. Neuroscience 97, 521-530.
34. Palombo E., Porrino L. J., Bankiewicz K. S., Crane A. M., Sokoloff L. and Kopin I. J. (1990) Local cerebral glucose utilization in monkeys with hemiparkinsonism induced by intracarotid infusion of the neurotoxin MPTP. J. Neurosci. 10, 860-869.
35. Pang Z. and Geddes J. W. (1997) Mechanisms of cell death induced by the mitochondrial toxin 3-nitropropionic acid: acute excitotoxic necrosis and delayed apoptosis. J. Neurosci. 17, 3064-3073.
36. Phelps M. E., Huang S. C., Hoffman E. J., Selin C., Sokoloff L. and Kuhl D. (1979) Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method. Ann. Neurol. 6, 371-388.
37. Reynolds D. S., Carter R. J. and Morton J. (1998) Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease. J. Neurosci. 18, 10116-10127.
38. Sokoloff L., Reivich M., Kennedy C., Des Rosiers M. H., Patlak C. S., Pettigrew K. D., Sakurada D. and Shinohara M. (1977) The (C-14) deoxy glucose method for the measurement of local cerebral glucose utilization: Theory, procedure, the normal values in the conscious and anesthetized albino rat. J. Neurochem. 28, 897-916.
39. Storgaard J., Kornblit B. T., Zimmer J., Bert J. and Gramsbergen P. (2000) 3-nitropropionic acid in organotypic striatal and cortico-striatal slice cultures is dependent on glucose and glutamate. Exp. Neurol. 164, 227-235.
40. Vis J. C., Verbeek M. M., De Waal R. M., Ten Donkelaar H. J. and Kremer H. P. (1999) 3-Nitropropionic acid induces a spectrum of Huntington's disease-like neuropathology in rat striatum. Neuropathol. Appl. Neurobiol. 25, 513-521.
41. Wyllie A. H., Kerr J. F. and Currie A. R. (1980) Cell death: the significance of apoptosis. Int. Rev. Cytol. 68, 251-306.
42. Wyllie A. H., Morris R. G., Smith A. L. and Dunlop D. (1984) Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J. Pathol. 142, 67-77.